Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

29.20
-1.4800-4.82%
Post-market: 29.200.00000.00%19:30 EDT
Volume:68.38K
Turnover:2.07M
Market Cap:29.70M
PE:-0.32
High:31.06
Open:30.20
Low:29.20
Close:30.68
52wk High:909.98
52wk Low:15.10
Shares:1.02M
Float Shares:679.70K
Volume Ratio:3.27
T/O Rate:10.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-90.9250
EPS(LYR):-335.2669
ROE:-153.84%
ROA:-31.51%
PB:-0.84
PE(LYR):-0.09

Loading ...

Quince Therapeutics Names Leone Patterson Audit, Compensation Committee Chair in Board Overhaul

Reuters
·
Yesterday

Leerink Partners Reaffirms Their Buy Rating on Quince Therapeutics (QNCX)

TIPRANKS
·
Sep 30

Quince Therapeutics to Host Virtual KOL Event on PH-ILD, BOS Treatment Landscape and LAM-001

Reuters
·
Sep 17

Quince Therapeutics Flags NASDAQ Noncompliance After Stockholders’ Equity Falls to ($35.32 Million)

Reuters
·
Sep 04

Quince Therapeutics President Charles Ryan to Exit Sept. 8

Reuters
·
Aug 28

Quince Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 25

Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy

TIPRANKS
·
Aug 20

Quince Therapeutics : Leerink Partners Adjusts Target Price to $68 from $4 to Reflect 1-for-20 Reverse Stock Split

THOMSON REUTERS
·
Aug 18

Quince Therapeutics Raises USD 115 Million in Private Placement of Series C Preferred Shares

Reuters
·
Aug 17

Quince Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quince Therapeutics Q2 Net Loss Widens on Acquisition Charges

Reuters
·
Aug 14

Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 14

Quince Therapeutics, Inc. Expected to Post a Loss of $17.88 a Share - Earnings Preview

Reuters
·
Aug 07

Quince Therapeutics - Brigette Roberts Conditionally Appointed as Chief Executive Officer - SEC Filing

THOMSON REUTERS
·
Aug 01

Quince Therapeutics Names Brigette Roberts CEO in Management Reshuffle

Reuters
·
Aug 01

Quince Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 01

Quince Therapeutics - Offers 15,470,099 Shares of Common Stock for Resale - SEC Filing

THOMSON REUTERS
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX) and Opus Genetics (IRD)

TIPRANKS
·
Jul 31

Quince Therapeutics : Oppenheimer Initiates Coverage with Outperform Rating; Price Target $82

THOMSON REUTERS
·
Jul 29

Quince Therapeutics Appoints Paul Yu to Chair New Pulmonary Scientific Advisory Board

Reuters
·
Jun 30